Your browser doesn't support javascript.
loading
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Revilla, Giovanna; Al Qtaish, Nuseibah; Caruana, Pablo; Sainz-Ramos, Myriam; Lopez-Mendez, Tania; Rodriguez, Francisco; Paez-Espinosa, Verónica; Li, Changda; Vallverdú, Núria Fucui; Edwards, Maria; Moral, Antonio; Pérez, José Ignacio; Escolà-Gil, Juan Carlos; Pedraz, José Luis; Gallego, Idoia; Corcoy, Rosa; Céspedes, María Virtudes; Puras, Gustavo; Mato, Eugènia.
Affiliation
  • Revilla G; Research Biomedical Institute (IIB) Sant Pau, C/Sant Quintí 77, 08041 Barcelona, Spain.
  • Al Qtaish N; Departament of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, C/Antoni M. Claret 167, 08025 Barcelona, Spain.
  • Caruana P; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
  • Sainz-Ramos M; Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
  • Lopez-Mendez T; NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
  • Rodriguez F; Pharmacy Department, College of Pharmacy, Amman Arab University, P.O. Box 2234, Amman 11953, Jordan.
  • Paez-Espinosa V; Research Biomedical Institute (IIB) Sant Pau, C/Sant Quintí 77, 08041 Barcelona, Spain.
  • Li C; Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
  • Vallverdú NF; NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
  • Edwards M; Bioaraba, NanoBioCel Research Group, 01009 Vitoria-Gasteiz, Spain.
  • Moral A; Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
  • Pérez JI; NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
  • Escolà-Gil JC; Bioaraba, NanoBioCel Research Group, 01009 Vitoria-Gasteiz, Spain.
  • Pedraz JL; Research Biomedical Institute (IIB) Sant Pau, C/Sant Quintí 77, 08041 Barcelona, Spain.
  • Gallego I; Department Clinical Biochemistry, School of Medicine, Pontificia Universidad Católica del Ecuador (PUCE), Av. 12 de Octubre 1076 y Roca, Quito 17012184, Pichincha, Ecuador.
  • Corcoy R; Research Biomedical Institute (IIB) Sant Pau, C/Sant Quintí 77, 08041 Barcelona, Spain.
  • Céspedes MV; Departament of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, C/Antoni M. Claret 167, 08025 Barcelona, Spain.
  • Puras G; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
  • Mato E; Research Biomedical Institute (IIB) Sant Pau, C/Sant Quintí 77, 08041 Barcelona, Spain.
Biomolecules ; 13(11)2023 11 13.
Article in En | MEDLINE | ID: mdl-38002329
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Nanoparticles Limits: Animals / Humans Language: En Journal: Biomolecules Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Nanoparticles Limits: Animals / Humans Language: En Journal: Biomolecules Year: 2023 Type: Article Affiliation country: Spain